Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Ito

Showing results (91-100 of 191) with videos related to

Pageof 20
Sort By:
Molecular and Clinical Oncology|June 23, 2016
Disseminated intravascular coagulation observed following treatment with gemtuzumab ozogamicin for relapsed/refractory acute promyelocytic leukemiaYoshiko Azuma, Aya Nakaya, Masaaki Hotta, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 6, 2023
Alectinib in a patient with ALK-positive non-small lung cancer unable to swallow capsulesYoshihisa Ishiura, Shosaku Nomura, Yuka Ishii, et al.
Clinical Immunology (Orlando, Fla.)|May 18, 2010
Thymic stromal lymphopoietin plays an adjuvant role in BCG-mediated CD8(+) cytotoxic T cell responses through dendritic cell activationHiroyuki Sugimoto, Tomoki Ito, Yoshitaro Torii, et al.
Internal Medicine (Tokyo, Japan)|September 7, 2022
Anti-MDA-5 Antibody-positive Dermatomyositis after Allogeneic Bone Marrow Transplantation for Acute Transformation of Chronic Myelogenous LeukemiaMariko Futamura, Yoshio Ozaki, Hidehiko Makino, et al.
International Journal of General Medicine|July 19, 2012
Effects of pitavastatin on plasminogen activator inhibitor-1 in hyperlipidemic patientsShosaku Nomura, Takehito Taniura, Akira Shouzu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2006
OX40 ligand shuts down IL-10-producing regulatory T cellsTomoki Ito, Yui-Hsi Wang, Omar Duramad, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|September 26, 2017
IL-33 Promotes the Induction and Maintenance of Th2 Immune Responses by Enhancing the Function of OX40 LigandNaoko Murakami-Satsutani, Tomoki Ito, Takahisa Nakanishi, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|May 24, 2014
IL-33 promotes the induction and maintenance of Th2 immune responses by enhancing the function of OX40 ligandNaoko Murakami-Satsutani, Tomoki Ito, Takahisa Nakanishi, et al.
Leukemia Research Reports|August 5, 2016
Enhanced international prognostic index in Japanese patients with diffuse large B-cell lymphomaAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
British Journal of Haematology|December 5, 2022
Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo-controlled, double-blind, parallel-group studyMasataka Kuwana, Tomoki Ito, Shugo Kowata, et al.
Pageof 20

Showing results (91-100 of 191) with videos related to

Sort By:
Pageof 20
Molecular and Clinical Oncology|June 23, 2016
Disseminated intravascular coagulation observed following treatment with gemtuzumab ozogamicin for relapsed/refractory acute promyelocytic leukemiaYoshiko Azuma, Aya Nakaya, Masaaki Hotta, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 6, 2023
Alectinib in a patient with ALK-positive non-small lung cancer unable to swallow capsulesYoshihisa Ishiura, Shosaku Nomura, Yuka Ishii, et al.
Clinical Immunology (Orlando, Fla.)|May 18, 2010
Thymic stromal lymphopoietin plays an adjuvant role in BCG-mediated CD8(+) cytotoxic T cell responses through dendritic cell activationHiroyuki Sugimoto, Tomoki Ito, Yoshitaro Torii, et al.
Internal Medicine (Tokyo, Japan)|September 7, 2022
Anti-MDA-5 Antibody-positive Dermatomyositis after Allogeneic Bone Marrow Transplantation for Acute Transformation of Chronic Myelogenous LeukemiaMariko Futamura, Yoshio Ozaki, Hidehiko Makino, et al.
International Journal of General Medicine|July 19, 2012
Effects of pitavastatin on plasminogen activator inhibitor-1 in hyperlipidemic patientsShosaku Nomura, Takehito Taniura, Akira Shouzu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 23, 2006
OX40 ligand shuts down IL-10-producing regulatory T cellsTomoki Ito, Yui-Hsi Wang, Omar Duramad, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|September 26, 2017
IL-33 Promotes the Induction and Maintenance of Th2 Immune Responses by Enhancing the Function of OX40 LigandNaoko Murakami-Satsutani, Tomoki Ito, Takahisa Nakanishi, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|May 24, 2014
IL-33 promotes the induction and maintenance of Th2 immune responses by enhancing the function of OX40 ligandNaoko Murakami-Satsutani, Tomoki Ito, Takahisa Nakanishi, et al.
Leukemia Research Reports|August 5, 2016
Enhanced international prognostic index in Japanese patients with diffuse large B-cell lymphomaAya Nakaya, Shinya Fujita, Atsushi Satake, et al.
British Journal of Haematology|December 5, 2022
Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo-controlled, double-blind, parallel-group studyMasataka Kuwana, Tomoki Ito, Shugo Kowata, et al.
Pageof 20